Inquiry Basket
Desmethyl Vc-seco-DUBA is an innovative biomedical product used in the treatment of various diseases. It exhibits potent anti-inflammatory properties, making it effective in managing chronic inflammation associated with autoimmune disorders. Its precise mechanism of action involves specifically targeting the overactive immune response and modulating inflammatory pathways. By alleviating inflammation, Desmethyl Vc-seco-DUBA offers promising therapeutic potential in conditions such as rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease.
| Catalog Number | Size | Price | Quantity | ||
|---|---|---|---|---|---|
| BADC-01466 | -- | $-- | Inquiry |
Desmethyl Vc-seco-DUBA, a potent cytotoxic compound widely utilized in cancer research and drug development, boasts a myriad of crucial applications. Here are four key applications:
Antibody-Drug Conjugates (ADCs): The versatile nature of Desmethyl Vc-seco-DUBA allows it to be intricately conjugated to antibodies tailored to specific malignant cell markers, culminating in the creation of ADCs that meticulously target and obliterate cancer cells. This innovative strategy not only mitigates the risk of inadvertent harm to healthy tissues but also amplifies the therapeutic efficacy of cancer treatments. ADCs incorporating this compound represent a nuanced and potentially game-changing departure from conventional chemotherapy, promising heightened effectiveness and improved safety profiles.
Cancer Cell Line Studies: In the realm of preclinical exploration, Desmethyl Vc-seco-DUBA serves as a powerful tool for evaluating its cytotoxic impact on a diverse array of cancer cell lines. Researchers delve into its potency, mode of action, and cellular responses to gauge its therapeutic viability. These investigations are pivotal for unraveling the intricate dance between cancer cells and treatment modalities, paving the way for optimized dosage regimens and a deeper comprehension of treatment outcomes.
Drug Synergy Studies: Embracing a collaborative approach, Desmethyl Vc-seco-DUBA plays a pivotal role in synergy studies, where it is paired with various anticancer agents to appraise potential synergistic effects. The amalgamation of this compound with other drugs unveils synergies that accentuate efficacy while mitigating resistance in cancer cells.
Customer Support
Providing excellent 24/7 customer service and support
Project Management
Offering 100% high-quality services at all stages
Quality Assurance
Ensuring the quality and reliability of products or services
Global Delivery
Ensuring timely delivery of products worldwide
BOC Sciences offers comprehensive services for ADC manufacturing, including antibody modification, linker chemistry, payload conjugation, and formulation development. In particular, our payload-linker customization service offers a convenient and fast raw material channel for many ADC researchers.
BOC Sciences provides one-stop site-specific conjugation services for amino acids, glycans, unnatural amino acids, and short peptide tags. In addition, cysteine conjugation, lysine conjugation, enzymatic conjugation, thio-engineered antibody can also be obtained quickly.
BOC Sciences offers a full range of linkers, including peptide linkers, PEG linkers, click chemistry, PROTAC linkers, non-cleavable linkers, etc. We also provide custom development services for chemically labile linkers and enzymatically cleavable linkers.
